Anti-human IL11RA therapy - Beijing Biocytogen
Alternative Names: Anti-human IL11RA antibodyLatest Information Update: 30 Jun 2023
At a glance
- Originator Beijing Biocytogen
- Class Antibodies; Hepatoprotectants
- Mechanism of Action Interleukin 11 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver disorders